Biomedical Sciences
Volume 2, Issue 3, May 2016, Pages: 16-23

 Review Article

Post-Transcriptional Gene Regulation by MicroRNA and RNA-Binding Protein

Tomoki Chiba1, Yoshiaki Ito1, Hiroshi Asahara1, 2, *

1Department of Systems BioMedicine, Graduate school of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

2Department of Molecular and Experimental Medicine, the Scripps Research Institute, La Jolla, USA

Email address:

(H. Asahara)

*Corresponding author

To cite this article:

Tomoki Chiba, Yoshiaki Ito, Hiroshi Asahara. Post-Transcriptional Gene Regulation by MicroRNA and RNA-Binding Protein. Biomedical Sciences. Vol. 2, No. 3, 2016, pp. 16-23. doi: 10.11648/j.bs.20160203.11

Received: July 4, 2016; Accepted: July 22, 2016; Published: August 22, 2016


Abstract: Recent advanced studies have demonstrated that post-transcriptional gene regulation is involved in many aspects of biological processes and in the pathogenesis of various types of disorders, such as neurodegenerative diseases, autoimmune diseases, and cancer. In addition to transcriptional regulation, spatially and temporally regulated gene expression is achieved by the post-transcriptional control of transcribed RNAs, including through splicing, export, stability, localization, and translation. These processes are regulated by the formation of ribonucleoprotein complexes with RNA-binding proteins and small non-coding RNAs. Here, we will describe the findings obtained from studies on mice deficient for individual RNA-binding proteins and microRNAs involved in maintaining homeostasis or causing disease.

Keywords: Post-Transcriptional Regulation, MicroRNA, RNA-Binding Protein, Knockout Mice


1. Introduction

Accumulating evidence clearly indicates that post-transcriptional gene regulation is essential for various aspects of biological processes [1-6]. Transcription of mRNA is the first step in gene expression, and changes in transcriptional rates caused by the assembly of transcription factors are critical determinants of the majority of temporal changes in mRNA levels in cells [7]. In addition, post-transcriptional regulation such as splicing; modification with an m7G cap and poly-adenylation at the 5ʹ- and 3ʹ-ends, respectively; nuclear export; stabilization; and localization is also important for shaping "peaked" responses such as receiving external stimuli and extending the duration of expression [7-10]. Furthermore, mRNA stabilization and/or degradation; RNA modifications such as methylation and pseudouridylation; and associations with the translational machinery affect the efficiency of protein synthesis [11-14]. These post-transcriptional events are regulated by the formation of ribonucleoprotein complexes with RNA-binding proteins (RBPs). In addition, small non-coding RNAs such as microRNAs (miRNAs) are also involved in regulation through the formation of RNA-induced silencing complexes (RISCs).

In this review, we will highlight the roles of the post-transcriptional regulation of gene expression in development, maintaining immune homeostasis, and the pathogenesis of autoimmune diseases and cancer, with insights from studies on knockout mouse models of individual miRNAs and RBPs.

2. MicroRNAs

MiRNAs are ~22-nucleotide single-stranded small non-coding RNAs that are highly conserved among eukaryotes and play a critical role in the post-transcriptional regulation of gene expression. miRNAs have a unique synthesis process [15]. Many miRNAs have their own transcription initiation region, and some miRNAs are located on introns of other genes or exist as a cluster of transcriptional units. First, an miRNA is transcribed by RNA polymerase II to produce a primary miRNA (pri-miRNA), which is a long primary transcript containing one or more miRNA. Drosha, a nuclear RNase III, then crops the pri-miRNA into a precursor miRNA (pre-miRNA), which has a hairpin loop structure and is then exported from the nucleus into the cytoplasm by Exportin 5 [16-18]. Finally, the pre-miRNA is cleaved by cytoplasmic RNase III Dicer to form short nucleotide duplexes, and either one of the single strands is incorporated into an Argonaute (Ago) protein complex, known as an RISC. The single-stranded RNA is now a mature miRNA and is able to bind a partial complementary sequence, mainly located on the 3ʹ-untranslated region (3ʹ-UTR) of the target mRNA, and impart its translation repression or degradation [19-21]. Because Dicer knockout mice display severe growth arrest at an early embryonic stage [22], miRNAs are regarded as critical factors for development. Recently, some loss-of-function studies revealed that individual miRNAs play critical roles in various biological processes such as development, homeostasis, and immune system function, and these roles are highlighted below.

2.1. MiR 17~92 Cluster

The miR-17~92 cluster contains miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92a-1, which are promoted by MYC (v-myc avian myelocytomatosis viral oncogene homolog) and are representative miRNAs that are considered "oncogenes" [23, 24]. miR-17~92 knockout mice show perinatal lethality with heart, lung, and skeletal defects, indicating that the miR-17~92 cluster is critical for development [25]. Knockout mice lacking miR-106a~363 and miR-106b~25, which are known as the miR-17~92 family, have no obvious phenotypes; however, mice with co-deletion of miR-17~92 with miR-106a~363 and miR-106b~25 die before embryonic day 15 [25], indicating that these clusters functionally cooperate in regulating embryonic development.

2.2. MiR-34/449

The miR-34/449 family contains miR-34a/b/c and miR-449a/b/c, constituting a conserved family in vertebrates, and seed sequence homology among miR-34/449 miRNAs predicts robust functional redundancy. Although the miR-34 family has been proposed as critical modulators of the p 53 pathway and potential tumor suppressors, miR-34 knockout mice exhibit normal development and do not display increased susceptibility to spontaneous, irradiation-induced, or c-Myc-initiated tumorigenesis [26]. On the other hand, miR-34/449 miRNAs are highly enriched in mucociliary epithelia that contain motile cilia, and miR-34/449 deletion in mice and frogs leads to defects in ciliogenesis. miR-34/449 knockout mice exhibit frequent postnatal mortality, with only ~40% surviving to adulthood [27]. These results indicate that the miR-34/449 family is essential for development.

2.3. MiR-1/126/205

The above examples are phenotypes of the deletion of an miRNA cluster or family in mice. However, severe developmental phenotypes in single-miRNA knockout mice have also been reported. miR-1 and miR-133 are muscle-specific miRNAs [28-32]. miR-1-2 knockout mice exhibit cardiac morphogenic, electrical conduction, and cell cycle defects and 50% lethality at weaning [33]. In addition to this miRNA, other single-miRNA knockout mice showing lethal phenotypes, such as knockout mice lacking miR-205 (100% neonatal lethality with compromised epidermal and hair follicle growth; [34]) and miR-126 (40-50% embryonic/perinatal lethality with angiogenesis defects; [35]), have also been reported.

2.4. MiR-140

Our group revealed that miRNA is important for cartilage development and homeostasis. miR-140 is specifically expressed in the cartilage of mouse embryos and zebrafish [36-38], and this expression is regulated by Sox 9, a master regulator of chondrogenesis [39]. Previous studies also found reduced miR-140 expression in human osteoarthritis (OA) cartilage [40, 41]. miR-140 knockout mice show a mild skeletal phenotype with a short stature, although the structure of the articular joint cartilage appeared grossly normal in 1-month-old miR-140 mutant mice. However, interestingly, miR-140−/− mice manifest age-related OA-like changes [37]. miR-140 directly regulates Adamts-5, which degrades aggrecan and is a critical enzyme for OA pathogenesis [37,42,43]. These findings demonstrate that miR-140 is required for skeletal development and cartilage homeostasis and protects against OA-like pathology via Adamts-5 regulation.

2.5. MiR-155

MiRNAs are critical regulators of not only development and homeostasis but also the immune system. miR-155 maps within an exon of the noncoding RNA bic [44, 45], its primary miRNA precursor [46]. bic/miR-155 shows greatly increased expression in activated B- and T-cells, macrophages, and dendritic cells (DCs) [46-50]. Increased expression of bic/miR-155 has been reported in B-cell lymphomas and solid tumors [51], and transgenic miR-155 mice have also been shown to develop B-cell malignancies [52], indicating that the miRNA might be linked to cancer. miR-155/bic knockout mice are immunodeficient and display increased lung airway remodeling [53], indicating that miR-155 plays a key role in the function of the immune system.

2.6. MiR-146

MiR-146a was initially discovered as an miRNA that was induced upon microbial infection [49]. miR-146a is induced by NF-kB and inhibits innate immune responses by repressing TRAF6 and IRAK1 [49], and miR-146a knockout mice show several immune defects. miR-146a null mice show hyperresponsiveness of macrophages to bacterial LPSs, which leads to an exaggerated inflammatory response in LPS-challenged mice [54]. Later in life, miR-146a knockout mice develop a spontaneous autoimmune disorder, characterized by splenomegaly, lymphadenopathy, and multiorgan inflammation; as a result, many die prematurely [54]. In addition, aged miR-146a knockout mice display an excessive production of myeloid cells and develop myeloid sarcomas and some lymphomas [54,55], suggesting that miR-146a can function as a tumor suppressor in the context of the immune system.

3. RNA-Binding Proteins

RBPs play pivotal roles post-transcriptionally in the regulation of gene expression. RBPs are estimated to be encoded in over 1,500 genes in the human genome and are known to be involved in inflammation and neurodegenerative disorders [56-58]. As with miRNAs, the binding specificity between cognate RNA and RBPs is determined by the primary RNA sequence. The most prominent example is the adenine (A) and uridine (U)-rich element (ARE) that is characterized by AUUUA or UUAUUUUAUU in the U-rich context. Over three decades ago, AREs were found in the 3ʹ-UTR of GM-CSF and TNFα and shown to destabilize mRNA [59,60]. A later study estimated that 5-8% of all mRNAs contain functional AREs and are involved in various biological processes, including the immune response, inflammation, and development [61,62]. The secondary structure, as well as the primary sequence, of mRNA is also a critical determinant of its specificity to cognate mRNAs. Although miRNAs and ARE-binding proteins are the most prominent examples of post-transcriptional regulation as mentioned above, a stem-loop structure that differed from the complementary sequence to any known miRNA and ARE was found in the 3ʹ-UTR of TNFα and named the conserved decay element [63,64]. We will describe the findings obtained from mice deficient in RBPs involved in development, reproduction, the immune system, and neural function.

3.1. Tristetraprolin Family

Tristetraprolin (TTP) is encoded by Zfp36 and composed of two CCCH-type zinc finger domains. Although TTP has been considered a DNA-binding transcription factor, later studies demonstrated that TTP binds directly to mRNA, especially to AREs [65]. Mice deficient in TTP appear normal after birth, but they show spontaneously severe myeloid hyperplasia, arthritis with bone erosion, dermatitis, conjunctivitis, glomerular mesangial thickening, high titers of anti-nuclear antibodies, and cachexia due to elevated production of TNFα by macrophages and neutrophils [66]. These inflammation-associated phenotypes are prevented by injection of a monoclonal antibody against TNFα. Consistent with this, mice lacking an ARE in the 3ʹ-UTR of TNFα show an auto-inflammatory phenotype resembling that of TTP-deficient mice [67]. These findings strongly suggested that TTP-mediated suppression of TNFα production is crucial for maintaining immune homeostasis in vivo. BRF1 and BRF2 are close homologues of TTP that possess CCCH-type zinc fingers that are very similar to that of TTP but differ in their N- and C-terminal ends. Unlike TTP-deficient mice, mice lacking BRF1 die at embryonic day 11 because of failure of chorioallantoic fusion [68]. Although BRF2-deficient mice are born at the expected Mendelian ratio, cells that originate from hematopoietic stem cells, including white and red blood cells and platelets, are greatly reduced, resulting in death within 2 weeks after birth [69]. Interestingly, it was reported that mice that lacked BRF1 and BRF2 during thymopoiesis developed a T cell acute lymphoblastic leukemia dependent on the oncogenic transcription factor Notch1. Thus, tristetraprolin families prevent the pathogenesis of autoimmune diseases and leukemia [70].

3.2. AUF1

AUF1 (also known as HNRNPD) binds to mRNAs containing an ARE and suppresses translational initiation by replacing translational initiation factor eIF4G and poly (A) binding protein [71]. AUF1-deficient mice have a higher susceptibility to endotoxin shock and die earlier compared to WT mice [72]. These differences were due to the excessive production of TNFα and IL-1β by macrophages. AUF1-deficient mice were shown to have a reduced number of splenocytes and develop spontaneously pruritic inflammatory skin disease with elevated serum IgE levels and T-cell hyper-proliferation, indicating that AUF1 is also involved in adaptive immune responses as well as in innate immunity [73]. Interestingly, AUF1 is also involved in maintainance of telomere length, and decreased survival and increased markers of aging are observed in late-generation AUF1 deficient mice [74].

3.3. TIA-1/TIAL-1

TIA-1 and TIAL-1 have well-defined RNA-recognition motifs that bind to AREs with high affinity and suppress mRNA translation through the formation of a 48S* pre-initiation complex, which is a translationally stalled complex, in processing body [11]. TIA-1-deficient mice spontaneously develop arthritis and die earlier of endotoxin shock compared to WT mice [75]. Macrophages derived from TIA-1-deficient mice produce higher amounts of TNFα and IL-1β, but not IL-6. Sucrose gradient analysis revealed that TNFα mRNAs had a higher degree of association with polysomes, which represent actively translating ribosomes, in TIA-1-deficient macrophages compared to normal macrophages. These results indicated that the translational suppression of inflammatory cytokines such as TNFα by TIA-1 is crucial for maintaining immune homeostasis in vivo. Similar to TIA-1 deficiency, partial lethality was also observed in mice lacking TIAL-1. In contrast to TIA-1-deficient mice, both male and female TIAL-1-deficient mice are sterile because they lack spermatogonia and oogonia, resulting from a primordial germ cell development defect [76]. These results indicated that the two related proteins, TIA-1 and TIAL-1, are involved in both the immune system and reproduction.

3.4. CUGBP1

CUGBP1, also known as CELF1, is a multifaceted RBP involved in the regulation of alternative splicing, stimulation of translation via the 5ʹ-UTR of cognate mRNAs, and mRNA decay by binding to guanine- and uridine-rich elements found in the 3ʹ-UTR of mRNA [11,77,78]. Mice deficient in CUGBP-1 are viable, but they display growth retardation [79]. Like TIAL-1 deficiency in mice, CUGBP-1 deficiency leads to impaired fertility in both male and female mice.

3.5. Hu Family

The Hu family is composed of four related genes: HuB, HuC, HuD, and HuR. The Hu family has three RRM domains and stimulates translation through binding to both AREs and polyA tails in the 3ʹ-UTR of mRNA [80-82]. On the other hand, cross-linked RNA immunoprecipitation with high-throughput sequence analyses revealed that Hu proteins also bind to intronic sequences of RNA and regulate alternative splicing [83, 84]. The expression of HuB, HuC, and HuD is restricted to neural cells, whereas HuR is expressed ubiquitously. It was reported that HuC- or HuD-deficient mice showed poor rotarod performance and seizure, suggesting that neural Hu proteins are indispensable for normal neuron functioning [84, 85]. In contrast to neural Hu proteins, HuR-deficient embryos exhibit a stage retardation phenotype and fail to survive beyond mid-gestation [86]. T-cell-specific deletion of HuR leads to resistance to experimental autoimmune encephalomyelitis (EAE), an experimental model of human multiple sclerosis, via lower levels of T-cell proliferation and IL-17 production [87]. Floxed HuR mice harboring lysozyme-driven Cre expression show higher susceptibility to endotoxin shock, inflammatory bowel disease, and colitis-associated cancer with excessive production of inflammatory cytokines and chemokines, indicating that HuR expression in myeloid cells, including macrophages and neutrophils, is indispensable for maintaining immune homeostasis [88]. These results indicated that the Hu family of proteins is required during embryonic and adult stages of life.

3.6. Regnase-1

Regnase-1 is encoded by Zc3h12a and induced immediately after exposure to ligands for Toll-like receptors. Regnase-1 has a CCCH-type zinc finger domain that has ribonuclease activity and binds to stem-loop structures found in a set of inflammatory genes, including IL-6 and IL-12p40 [89]. Interestingly, Regnase-1 specifically cleaves and degrades translationally active mRNAs and is dependent on UPF1, an essential component of nonsense-mediated decay [90]. Regnase-1-deficient mice spontaneously suffer from severe anemia and fetal autoimmune diseases and die within 12 weeks [89]. An increased number of activated and/or memory phenotype T-cells, which are CD44 positive and CD62L negative, were observed in the spleen and lymph nodes of mice lacking Regnase-1. Plasma cells, which are known to be antibody-secreting cells, were dramatically increased in the spleen, leading to the excessive production of antibodies against nuclear contents and dsDNA. T-cell-specific deletion of Regnase-1 also results in fetal autoimmune diseases and autoantibody production, as seen in Regnase-1-deficient mice [91]. CD4+ T-cells lacking Regnase-1 produce large amount of IFNγ, IL-4, and IL-17, which are representative cytokines for Th1, Th2, and Th17 cells, respectively. Severe autoimmune phenotypes observed in T-cell-specific Regnase-1 deficiency are partially dependent on the expression of c-Rel, a transcription factor composed of NF-κB and a target of Regnase-1, because mice deficient in both Regnase-1 and c-Rel exhibit a reduced number of plasma cells and activated T-cells. Therefore, Regnase-1 expression is indispensable for the maintenance of immune homeostasis.

3.7. Roquin

The sanroque mouse strain, which exhibits a severe autoimmune disease, was established by ethylnitrosourea-induced mutagenesis [92]. This mutant strain harbors a point mutation in which Met 199 is replaced with Arg within the ROQ domain of Roquin, and the mice exhibit a lupus-like pathology with higher amounts of anti-nuclear and dsDNA autoantibodies due to elevated expression of ICOS, which is a co-stimulatory receptor that facilitates follicular helper T-cell differentiation [93,94]. This mutant strain also has increased susceptibility to endotoxin shock and autoantibody-induced arthritis [95]. Roquin (Roquin-1) and its homologue Roquin-2 have a ROQ domain that binds to the stem-loop structure of mRNAs found in the 3ʹ-UTR of ICOS, TNFα, and IL-6 and degrades target mRNA via localization to P-bodies, followed by Caf-1-dependent deadenylation and degradation [64,90,93,95,96]. Although the complete loss of Roquin-1 or Roquin-2 in mice leads to perinatal lethality, lupus-like symptoms as seen in sanroque mutants are not observed in Roquin-1- or Roquin-2-deficient mice [97, 98]. However, mice lacking both Roquin-1 and Roquin-2 in T-cells exhibit an increased number of follicular helper T-cells and germinal center B cells, and develop lung inflammation and gastritis, indicating that Roquin-1 and Roquin-2 have redundant roles in the regulation of autoantibody production in a T-cell autonomous manner [98, 99].

3.8. ARID5a

The AT-rich interaction domain (ARID) is an ancient DNA-binding domain that is well conserved throughout evolution [100]. Interestingly, ARID5a also binds to single-strand RNAs and stabilizes a set of mRNAs such as IL-6 and STAT3 to facilitate their expression. As in the case of Regnase-1, ARID5a recognizes stem-loop structures via the ARID domain and prevents the binding of Regnase-1 to protect against the degradation of cognate mRNAs [101]. ARID5a is highly expressed in LPS-activated macrophages and Th17 cells, which are IL-17-secreting CD4+ T-cells involved in autoimmune diseases. Mice deficient in ARID5a show resistance to EAE, indicating that ARID5a is crucial for Th17-mediated immunopathology to stabilize IL-6 and STAT3 [102].

4. Conclusion

The findings described above highlight the importance of post-transcriptional regulation by miRNAs and RBPs in the pathogenesis of autoimmune diseases and cancer as well as in normal development. miR-16 is required for the rapid degradation of TNFα mRNA dependent on TTP, indicating that miRNAs and RBPs cooperatively regulate identical target mRNAs [103]. Recently, small compounds that regulate the alternative splicing of SMN2, the gene responsible for spinal muscular atrophy (SMA), were developed, and administrating them to Δ7 mice, a model of severe SMA, improved motor neuron function by increasing the expression of SMN protein and extending its life span [104]. Therefore, elucidating the mechanisms underlying post-transcriptional gene expression will provide new insights into novel therapeutic approaches for treating congenital diseases, autoimmune diseases, and cancer.

Acknowledgments

This work is supported by Grain-in-Aid from for Scientific Research on Innovative Areas (26113008), the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency /Japan Agency for Medical Research and Development (1A166), and Grants from the NIH (Grant Number: AR050631 and AR065379).


References

  1. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nature reviews.Immunology 2010 jan;10(1):24-35.
  2. Morris AR, Mukherjee N, Keene JD. Systematic analysis of posttranscriptional gene expression. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2010;2(2):162-180.
  3. Kojima S, Shingle DL, Green CB. Post-transcriptional control of circadian rhythms. J Cell Sci 2011;124(Pt 3):311-320.
  4. van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nature Reviews Cancer 2011 aug;11(9):644-656.
  5. Pilaz L, Silver DL. Post-transcriptional regulation in corticogenesis: how RNA-binding proteins help build the brain. Wiley Interdisciplinary Reviews: RNA 2015;6(October):501-515.
  6. Nishikura K. A-to-I editing of coding and non-coding RNAs by ADARs. Nature Reviews Molecular Cell Biology 2015 dec;17(2):83-96.
  7. Rabani M, Levin JZ, Fan L, Adiconis X, Raychowdhury R, Garber M, et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol 2011;29(5):436-442.
  8. Elkon R, Zlotorynski E, Zeller KI, Agami R. Major role for mRNA stability in shaping the kinetics of gene induction. BMC Genomics 2010;11:259.
  9. Rabani M, Raychowdhury R, Jovanovic M, Rooney M, Stumpo DJ, Pauli A, et al. High-resolution sequencing and modeling identifies distinct dynamic RNA regulatory strategies. Cell 2014;159(7):1698-1710.
  10. Bhatt DM, Pandya-Jones A, Tong A, Barozzi I, Lissner MM, Natoli G, et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012 jul;150(2):279-290.
  11. Ivanov P, Anderson P. Post-transcriptional regulatory networks in immunity. Immunol Rev 2013;253:253-272.
  12. Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes and Development 2015;29:1343-1355.
  13. Carlile TM, Rojas-duran MF, Zinshteyn B, Shin H, Bartoli KM, Gilbert WV. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 2014;515(7525):143-146.
  14. Truitt ML, Ruggero D. New frontiers in translational control of the cancer genome. Nature Reviews Cancer 2016 apr;16(5):288-304.
  15. Ceribelli, A., Nahid, M. A., Satoh, M. & Chan, E. K. MicroRNAs in rheumatoid arthritis. FEBS Lett 2011 585, 3667-3674.
  16. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003 425, 415-419.
  17. Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003 17, 3011-3016.
  18. Han, J. et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004 18, 3016-3027.
  19. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001 409, 363-366.
  20. Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001 293, 834-838.
  21. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A. & Baltimore, D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010 10, 111-122.
  22. Bernstein, E. et al. Dicer is essential for mouse development. Nat Genet 2003 35, 215-217.
  23. Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005 65, 9628-9632.
  24. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 2005 435, 828-833.
  25. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008 132, 875-886.
  26. Concepcion, C. P. et al. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet 2012 8, e1002797.
  27. Song, R. et al. miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature 2014 510, 115-120.
  28. Chen, J. F. et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006 38, 228-233.
  29. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 2001 294, 853-858.
  30. Sokol, N. S. & Ambros, V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005 19.
  31. Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005 436, 214-220.
  32. Kwon, C., Han, Z., Olson, E. N. & Srivastava, D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci U S A 2005 102, 18986-18991.
  33. Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007 129, 303-317.
  34. Wang, D. et al. MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway. Nat Cell Biol 2013 15, 1153-1163.
  35. Wang, S. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008 15, 261-271.
  36. Wienholds, E. et al. MicroRNA expression in zebrafish embryonic development. Science 2005 309, 310-311.
  37. Miyaki, S. et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010 24, 1173-1185.
  38. Tuddenham, L. et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006 580, 4214-4217.
  39. Yamashita, S. et al. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem 2012 287, 22206-22215.
  40. Miyaki, S. et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009 60, 2723-2730.
  41. Iliopoulos, D., Malizos, K. N., Oikonomou, P. & Tsezou, A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008 3, e3740.
  42. Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005 434, 644-648
  43. Stanton, H. et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005 434, 648-652
  44. Tam, W., Ben-Yehuda, D. & Hayward, W. S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997 17, 1490-1502.
  45. Tam, W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001 274, 157-167.
  46. Eis, P. S. et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005 102, 3627-3632.
  47. Haasch, D. et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 2002 217, 78-86.
  48. van den Berg, A. et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 2003 37, 20-28.
  49. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006 103, 12481-12486.
  50. Stetson, D. B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006 24, 93-103.
  51. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006 6, 857-866.
  52. Costinean, S. et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006 103, 7024-7029.
  53. Rodriguez, A. et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007 316, 608-611.
  54. Boldin, M. P. et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011 208, 1189-1201.
  55. Zhao, J. L. et al. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A 2011 108, 9184-9189
  56. Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nature Reviews Genetics 2014;15(12):829-845.
  57. Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 2013;154(4):727-736.
  58. Cooper TA, Wan L, Dreyfuss G. RNA and Disease. Cell 2009;136(4):777-793.
  59. Shaw G, Kamen R. A Conserved AU Sequence from the 3 ' Untranslated Region of GM-CSF mRNA Mediates Selective mRNA Degradation. 1986;46:659-667.
  60. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A 1986;83(6):1670-1674.
  61. Bakheet T. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 2006 jan;34(90001):D111-D114.
  62. Barreau C. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005 dec;33(22):7138-7150.
  63. Stoecklin G, Lu M, Rattenbacher B, Moroni C. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Mol Cell Biol 2003;23(10):3506-3515.
  64. Leppek K, Schott J, Reitter S, Poetz F, Hammond MC, Stoecklin G. Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell 2013 may;153(4):869-881.
  65. Blackshear PJ, Lai WS, Kennington EA, Brewer G, Wilson GM, Guan X, et al. Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J Biol Chem 2003;278(22):19947-19955.
  66. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, et al. A Pathogenetic Role for TNFα in the Syndrome of Cachexia, Arthritis, and Autoimmunity Resulting from Tristetraprolin (TTP) Deficiency. Immunity 1996 may;4(5):445-454.
  67. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements. Immunity 1999;10(3):387-398.
  68. Stumpo DJ, Byrd Na, Phillips RS, Ghosh S, Maronpot RR, Castranio T, et al. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol 2004 jul;24(14):6445-6455.
  69. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Yang JC, et al. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 2009;114(12):2401-2410.
  70. Hodson DJ, Janas ML, Galloway A, Bell SE, Andrews S, Li CM, et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol 2010;11(8):717-724.
  71. Lu J, Bergman N, Sadri N, Schneider RJ. Assembly of AUF1 with eIF4G-poly(A) binding protein complex suggests a translation function in AU-rich mRNA decay. RNA 2006;12(5):883-893.
  72. Lu J, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes {\&} development 2006 nov;20(22):3174-3184.
  73. Sadri N, Schneider RJ. Auf1 / Hnrnpd-Deficient Mice Develop Pruritic Inflammatory Skin Disease. J Invest Dermatol 2009:657-670.
  74. Pont AR, Sadri N, Hsiao SJ, Smith S, Schneider RJ. MRNA Decay Factor AUF1 Maintains Normal Aging, Telomere Maintenance, and Suppression of Senescence by Activation of Telomerase Transcription. Mol Cell 2012;47(1):5-15.
  75. Piecyk M, Wax S, Beck aR, Kedersha N, Gupta M, Maritim B, et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 2000;19(15):4154-4163.
  76. Beck ARP, Miller IJ, Anderson P, Streuli M. RNA-binding protein TIAR is essential for primordial germ cell development. Proc Natl Acad Sci U S A 1998;95(5):2331-2336.
  77. Moraes KCM, Wilusz CJ, Wilusz J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA 2006;12(6):1084-1091.
  78. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, SternJohn JR, et al. Conserved GU-Rich Elements Mediate mRNA Decay by Binding to CUG-Binding Protein 1. Mol Cell 2008;29(2):263-270.
  79. Kress C, Gautier-Courteille C, Osborne HB, Babinet C, Paillard L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol 2007;27(3):1146-1157.
  80. Abe R, Sakashita E, Yamamoto K, Sakamoto H. Two different RNA binding activities for the AU-rich element and the poly (A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res 1996; 24 (24): 4895-4901.
  81. Ma W, Chung S, Furneaux H. The Elav-like proteins bind to AU-rich elements and to the poly (A) tail of mRNA. 1997; 25 (18): 3564-3569.
  82. Fukao A, Sasano Y, Imataka H, Inoue K, Sakamoto H, Sonenberg N, et al. The ELAV Protein HuD Stimulates Cap-Dependent Translation in a Poly(A)- and eIF4A-Dependent Manner. Mol Cell 2009; 36 (6): 1007-1017.
  83. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, et al. Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability. Mol Cell 2011 aug; 43 (3): 327-339.
  84. Ince-Dunn G, Okano HJ, Jensen KB, Park WY, Zhong R, Ule J, et al. Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability. Neuron 2012; 75 (6): 1067-1079.
  85. Akamatsu W, Fujihara H, Mitsuhashi T, Yano M, Shibata S, Hayakawa Y, et al. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc Natl Acad Sci U S A 2005; 102 (12): 4625-4630.
  86. Katsanou V, Milatos S, Yiakouvaki A, Sgantzis N, Kotsoni A, Alexiou M, et al. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol Cell Biol 2009; 29 (10): 2762-2776.
  87. Chen J, Cascio J, Magee JD, Techasintana P, Gubin MM, Dahm GM, et al. Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitis. J Immunol 2013; 191 (11): 5441-5450.
  88. Yiakouvaki A, Dimitriou M, Karakasiliotis I, Eftychi C, Theocharis S, Kontoyiannis DL. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J Clin Invest 2012; 122 (1): 48-61.
  89. Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T, et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 2009; 458 (7242): 1185-1190.
  90. Mino T, Murakawa Y, Fukao A, Vandenbon A, Wessels HH, Ori D, et al. Regnase-1 and roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms. Cell 2015; 161 (5): 1058-1073.
  91. Uehata T, Iwasaki H, Vandenbon A, Matsushita K, Hernandez-Cuellar E, Kuniyoshi K, et al. Malt1-induced cleavage of regnase-1 in CD4 (+) helper T cells regulates immune activation. Cell 2013 may; 153 (5): 1036-1049.
  92. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005 may; 435 (7041): 452-458.
  93. 93. Yu D, Tan AH, Hu X, Athanasopoulos V, Simpson N, Silva DG, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007 nov; 450 (7167): 299-303.
  94. Pratama A, Ramiscal RR, Silva DG, Das SK, Athanasopoulos V, Fitch J, et al. Roquin-2 shares functions with its paralog roquin-1 in the repression of mrnas controlling t follicular helper cells and systemic inflammation. Immunity 2013; 38 (4): 669-680.
  95. Athanasopoulos V, Barker A, Yu D, Tan AHM, Srivastava M, Contreras N, et al. The ROQUIN family of proteins localizes to stress granules via the ROQ domain and binds target mRNAs. FEBS Journal 2010; 277 (9): 2109-2127.
  96. Glasmacher E, Hoefig KP, Vogel KU, Rath N, Du L, Wolf C, et al. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat Immunol 2010; 11 (8): 725-733.
  97. Bertossi A, Aichinger M, Sansonetti P, Lech M, Neff F, Pal M, et al. Loss of Roquin induces early death and immune deregulation but not autoimmunity. J Exp Med 2011; 208 (9): 1749-1756.
  98. Vogel KU, Edelmann SL, Jeltsch KM, Bertossi A, Heger K, Heinz GA, et al. Roquin paralogs 1 and 2 redundantly repress the icos and ox40 costimulator mrnas and control follicular helper t cell differentiation. Immunity 2013; 38 (4): 655-668.
  99. Jeltsch KM, Hu D, Brenner S, Z\oller J, Heinz Ga, Nagel D, et al. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T (H)17 differentiation. Nat Immunol 2014 nov; 15 (11): 1079-1089.
  100. Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics 2005; 86 (2): 242-251.
  101. Masuda K, Ripley B, Nishimura R, Mino T, Takeuchi O, Shioi G, et al. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo. Proc Natl Acad Sci U S A 2013 may; 9 (17).
  102. Masuda K, Ripley B, Nyati KK, Dubey PK, Zaman MM, Hanieh H, et al. Arid5a regulates naive CD4 + T cell fate through selective stabilization of Stat3 mRNA. J Exp Med 2016 apr; 213 (4): 605-619.
  103. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, et al. Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability. Cell 2005; 120 (5): 623-634.
  104. Naryshkin Na, Weetall M, Dakka A, Narasimhan J, Zhao X, Feng Z, et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science (New York, N.Y.) 2014 aug; 345 (6197): 688-693.

Article Tools
  Abstract
  PDF(217K)
Follow on us
ADDRESS
Science Publishing Group
548 FASHION AVENUE
NEW YORK, NY 10018
U.S.A.
Tel: (001)347-688-8931